Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 22.23M P/E - EPS this Y - Ern Qtrly Grth -
Income -2.81M Forward P/E - EPS next Y - 50D Avg Chg 7.00%
Sales 25k PEG - EPS past 5Y - 200D Avg Chg 2.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -50.00%
Recommedations - Quick Ratio 10.43 Shares Outstanding 417.56M 52W Low Chg 50.00%
Insider Own 4.70% ROA -95.87% Shares Float 397.73M Beta 1.02
Inst Own - ROE -171.10% Shares Shorted/Prior -/- Price 0.06
Gross Margin -3.12% Profit Margin - Avg. Volume 403,981 Target Price -
Oper. Margin -3,868.96% Earnings Date Nov 4 Volume 382,522 Change -4.76%
About VIVOS INC

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

RDGL Chatroom

User Image zoomnewm Posted - 1 day ago

$RDGL https://x.com/isopetforcancer/status/1859217943588171854?s=61

User Image Doccjc62 Posted - 2 days ago

$RDGL Man has IHub really gone downhill. Looks like SC8 has taken over the board and any post trying to refute his FUD or bs ,gets reported and taken down. For new investors, SC8,(SChuit here) is a disgruntled ex employee that got fired by Dr Korenko. Read his posts and you'll see his hatred towards Dr Korenko. He has zero skin in the game, and is here just to try and ruin the company and Dr Korenko's reputation. Best to ignore.

User Image Rogggggg Posted - 2 days ago

$RDGL hopefully the company is being transparent, if so, this is getting close to a great buy according to their timeline.

User Image Aknaka21 Posted - 3 days ago

$RDGL https://ih.advfn.com/stock-market/USOTC/vivos-qb-RDGL/stock-news/94936438/form-253g2

User Image Fireballmillionaire Posted - 3 days ago

$RDGL I have always thought it was a great product without the human side approved.. There's a ton of money to be made in the pet industry.. Obviously not a millionaire maker without human use approved.. but still a solid product with lots of backing. Rollout is happening!!

User Image GRIG330 Posted - 3 days ago

$RDGL BULLISH. New FDA leadership coming in will be much friendlier towards companies that have both innovative and SAFE therapies that can save human lives. Although I suspect we are near the finish line already, the coming Admin’s polices will no doubt be helpful. And I’m going to preemptively say SHUT THE F UP to Serpent / SC8 and all the other clowns on here.

User Image Rogggggg Posted - 3 days ago

$RDGL does the fda not accept results just for phase 3 or will this affect Rdgl?

User Image Aerovestorman Posted - 4 days ago

$RDGL What kind of person gets joy from another’s misfortune? This freak has bashed this penny stock ONLY, since August. Nothing else! He is clearly paid to undermine the company. No other possible explanation.

User Image Serpent_trader1 Posted - 5 days ago

$RDGL great work guys !

User Image Doccjc62 Posted - 6 days ago

$RDGL Why spend so much time bashing a stock ? I doubt he’s short the stock . May want cheaper shares ? Another disgruntled ex employee? Works for a competitor? Sad life you lead Serpent.

User Image Serpent_trader1 Posted - 6 days ago

$RDGL if it continues to fall, next resistance is in the .07 range

User Image Serpent_trader1 Posted - 6 days ago

$RDGL this company is going down the drain

User Image Barzimeron Posted - 6 days ago

$RDGL ok. Hit my first target on shares. Now looking at add 30k more.

User Image Daybyday5 Posted - 6 days ago

$RDGL https://archive.fast-edgar.com/20241113/AM22D22CZZ2RO2PN229L22Y2APQGRZ22Z262/

User Image Daybyday5 Posted - 6 days ago

$RDGL Good read...... The continued deployment of the precision radionuclide therapy products and a worldwide regulatory approval effort will require additional resources and personnel. The principal variables in the timing and amount of spending for the precision radionuclide therapy products in the next 12 to 24 months will be the FDA’s classification of the Company’s precision radionuclide therapy products as Class II or Class III devices (or otherwise) and any requirements for additional studies which may possibly include clinical studies. Thereafter, the principal variables in the amount of the Company’s spending and its financing requirements would be the timing of any approvals and the nature of the Company’s arrangements with third parties for manufacturing, sales, distribution and licensing of those products and the products’ success in the U.S. and elsewhere. The Company intends to fund its activities through strategic transactions such as licensing and partnership agreements

User Image Doccjc62 Posted - 6 days ago

$RDGL Human trials in Southeast Asia will start before human trials in the United States . The company is still pursuing the IDE and will be doing human trials at the Mayo Clinic once the IDE is granted . Human trials could start this year . The science works . Successfully treating cancer …. Wonder what that will do to the share price . Ignore all the noise

User Image Serpent_trader1 Posted - 6 days ago

$RDGL absolutely dying in laughter right now that this company can’t start trials in the United States. So they have to go overseas with less regulations.

User Image Serpent_trader1 Posted - 6 days ago

$RDGL pretty sure this is down 50%

User Image BCAT44 Posted - 1 week ago

$RDGL - Timing is everything!

User Image MnWalleye1 Posted - 1 week ago

$RDGL Any way you slice it human trails IS good.

User Image Doccjc62 Posted - 1 week ago

$RDGL We're about to start human trials.Finally! The science works in animals(IsoPet),,, now we're about to find out if it works in humans. No reason to believe it won't. Where will the share price be once we have those successful human trials? Imagine the headlines,,,"Successful cancer treatment"

User Image Serpent_trader1 Posted - 1 week ago

$RDGL almost done 50% in a month. Imagine listen to the pumpers pumping.

User Image anderson800 Posted - 1 week ago

$RDGL I don't blame people for losing patience and cutting and running when the rest of the market has been doing so well.

User Image Serpent_trader1 Posted - 1 week ago

$RDGL are they closing the company?

User Image anderson800 Posted - 1 week ago

$RDGL What the hell is that open?

User Image zoomnewm Posted - 1 week ago

$RDGL https://x.com/isopetforcancer/status/1857067791150354503?s=61

User Image Rogggggg Posted - 1 week ago

$RDGL let’s get this straight… I’m not bashing the company what so ever, if anything im bashing your idea/ what you said.. How are you talking about BO when they can’t even get their ide approved to start trails and are now going overseas?

User Image Doccjc62 Posted - 1 week ago

$RDGL Roggggg bashing the stock cause he’s trying to get cheap shares ,,,, If you believe what you post , why are you trying to buy shares ?

User Image Rogggggg Posted - 1 week ago

$IOVA $RDGL $TGTX $AYTU from penny stocks to micro caps to small caps every biotech stock board has one thing in common.. “BO imminent”😂😂😂

User Image zoomnewm Posted - 1 week ago

$RDGL https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318712653&type=PDF&symbol=RDGL&cdn=7fb689c3b2a606997724ea44fe85bbcd&companyName=Vivos+Inc&formType=10-Q&formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&dateFiled=2024-11-13

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Korenko Michael K CEO AND PRESIDENT CEO AND PRESIDENT Oct 18 Buy 0.0536 100,000 5,360 9,985,090 10/19/23
POLLACK MICHAEL H INTERIM CFO INTERIM CFO Mar 24 Sell 0.0624 16,000 998 03/27/23
Korenko Michael K CEO AND PRESIDENT CEO AND PRESIDENT Dec 15 Buy 0.0466 100,000 4,660 9,885,090 12/15/22
Korenko Michael K CEO AND PRESIDENT CEO AND PRESIDENT Nov 17 Buy 0.0517 200,000 10,340 9,785,090 11/18/22
Korenko Michael K CEO AND PRESIDENT CEO AND PRESIDENT Mar 27 Buy 0.06 100,000 6,000 9,584,890 03/29/22